Glucagon Patent Expiration
Glucagon is Used for quickly raising blood sugar levels in cases of severe hypoglycemia. It was first introduced by Eli Lilly And Co
Glucagon Patents
Given below is the list of patents protecting Glucagon, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Baqsimi | US10765602 | Medication delivery systems and methods | Sep 23, 2039 | Amphastar Pharms Inc |
| Baqsimi | US10894133 | Device for dispensing a fluid product | Jan 03, 2038 | Amphastar Pharms Inc |
| Gvoke Hypopen | US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Hypopen | US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Kit | US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Pfs | US11590205 | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Gvoke Pfs | US9649364 | Methods for producing stable therapeutic formulations in aprotic polar solvents | Apr 22, 2036 | Xeris |
| Baqsimi | US10213487 | Nasal powder formulation for treatment of hypoglycemia | Feb 16, 2036 | Amphastar Pharms Inc |
| Baqsimi | US6938798 | Fluid or powdery product dispensing device |
Jan 03, 2022
(Expired) | Amphastar Pharms Inc |
Glucagon's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List